Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease

doi:10.3748/wjg.119898

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 35

This Article

(6)

(0)

(50)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Evidence Review

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Sep 21, 2026; 32(35): 119898
Published online Sep 21, 2026. doi: 10.3748/wjg.119898

Table 2 Overview of risk factors associated to metabolic dysfunction-associated steatotic liver disease

Obesity-associated risk factors of MASLD
Lifestyle choices: Poor dietary habits; Less physical activity
Inherent risk factors: Genetic predisposition; Race/ethnicity (hispanic race); Sex (men); Epigenetic influences
Influence of metabolic factors: Dyslipidemia; Insulin resistance; Type 2 diabetes; Hypertension
Pathological processes: Gut microbiota; Adipokine imbalance; Systemic inflammation; Oxidative stress; Immune system imbalance; Hepatic steatosis

MASLD: Metabolic dysfunction-associated steatotic liver disease.

Full Size Table

Citation: Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Garcia-Bañuelos J, Petri MH, Armendariz-Borunda J. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease. World J Gastroenterol 2026; 32(35): 119898
URL: https://www.wjgnet.com/1007-9327/full/v32/i35/119898.htm
DOI: https://dx.doi.org/10.3748/wjg.119898

Gutiérrez-Cuevas J, Sandoval-Rodriguez A, Garcia-Bañuelos J, Petri MH, Armendariz-Borunda J. Interplay between cardiometabolic risk factors in metabolic dysfunction-associated steatotic liver disease: Clinical evidence on cardiovascular disease. World J Gastroenterol 2026; 32(35): 119898 [DOI: 10.3748/wjg.119898]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.